S&P 5007,573.44-1.50%
Dow Jones53,042.29-0.59%
Nasdaq25,026.10-2.76%
FTSE 10010,899.68+0.65%
DAX26,449.30-0.70%
Nikkei 22561,077.90-1.79%
Gold4,107.60+0.85%
Crude Oil89.71+1.80%
Bitcoin78,612.64-2.26%
Ethereum2,353.71-2.85%
EUR / USD1.1219-0.14%
GBP / USD1.3474+0.03%
Insight Analytics
Insight Analytics
Visit Insight →
EL
Guidance
Q1 FY2027

Estée Lauder Q1 Beats on All Fronts, Lifts Full-Year Guide

Organic sales rose 6%, adjusted EPS more than doubled, and management raised the full-year outlook across sales, margin, and cash flow.

By Insight AnalyticsPublished Nov 2, 2026 · 2 min readSource: SEC 8-K Item 2.02 · About our coverage
Estée Lauder's broad portfolio of skincare and beauty products drove a 6% organic sales gain in Q1.
Estée Lauder's broad portfolio of skincare and beauty products drove a 6% organic sales gain in Q1.Photo by Polina Tankilevitch on Pexels

Estée Lauder (NYSE: EL) just posted numbers that leave little room for quibbling. Management responded by lifting full-year guidance across sales, margin, and cash flow. Whether this sticks depends on what happens after the calendar flips, when comparisons stiffen and geopolitical noise threatens to intrude.

First-quarter net sales climbed 7% to $3.715 billion, clearing the $3.653 billion consensus. Organic growth hit 6%, with every region and nearly every category contributing. Adjusted diluted EPS of $0.72 more than doubled from $0.32 a year ago and blew past the $0.51 estimate. Gross margin widened 230 basis points to 75.7%, as procurement savings, manufacturing efficiencies, and pricing power swallowed inflation whole.

Consumer demand for prestige beauty lifted adjusted EPS more than double year over year.
Consumer demand for prestige beauty lifted adjusted EPS more than double year over year.Photo by Alan W on Pexels

Fragrance led the charge. Organic sales there jumped 20%, with Le Labo, TOM FORD, Jo Malone London, and KILIAN PARIS all posting double-digit gains. Le Labo's City Exclusives, including the new Beijing scent Shiu 25, plus TOM FORD's Tobacco Chocolat and Ombré Leather Reserve, did the heavy lifting. Skin Care rose 4% organic, propelled by La Mer's The Concentrate Serum and The Ordinary's widening distribution. Makeup scraped together 1% growth; M·A·C's lip launches offset weakness at the flagship Estée Lauder brand.

Mainland China delivered the quarter's most pleasant surprise. Net sales rose 15% reported and 9% organic, a sharp acceleration from recent trends. Travel retail at Beijing and Shanghai airports stabilized. Hainan online improved. Asia/Pacific grew 10% organic overall. The Americas managed 4% organic growth, aided by expanded distribution at Sephora and on Amazon.

The margin story matters most for the investment case. Adjusted operating margin hit 12.1%, up from 7.3% a year ago. That 480bp expansion came from operating leverage and gross margin gains, which funded an 8% increase in consumer-facing investments. This looks like structural savings from the Beauty Reimagined restructuring program, not one-off cost cuts.

The guidance raise is comprehensive. Organic sales growth now expected at 4.0% to 5.5%, up from 3% to 5%. Adjusted operating margin lifted to 12.9% to 13.7% from 12.7% to 13.5%. Adjusted EPS raised to $3.20 to $3.45 from $3.10 to $3.35. Operating cash flow guidance bumped to $1.4 billion to $1.5 billion from $1.3 billion to $1.4 billion.

Management's hedging deserves attention. The outlook assumes no deterioration in the geopolitical landscape, including tariffs and consumer sentiment. First-half strength partly reflects easier travel retail comparisons and a front-loaded new-product calendar. Second-half growth in EUKEM depends on lapping last year's Middle East disruption. Forest Essentials, acquired in October, won't move the needle in fiscal 2027.

The key variable: margin expansion pace in the second half. Hold adjusted operating margins near 13% while lapping tougher comparisons, and the structural improvement thesis gains credibility. Let margin compression return as consumer investment ramps, and the stock's rerating stalls. For now, Estée Lauder has produced the kind of quarter that makes a turnaround narrative feel earned.

Coverage of The Estée Lauder Companies Inc. (EL) Q1 FY2027. Insight News is a publication of Insight Analytics. Coverage is informational, not investment advice.

Generated by AI from the SEC filing linked in the sidebar. Numbers and quotes are drawn directly from the source document. Spot an error? support@insightanalytics.io.